Enlivex Therapeutics Ltd. (TLV:ENLV)
351.80
-14.40 (-3.93%)
May 14, 2025, 2:36 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 84.14 million as of May 14, 2025. Its market cap has decreased by -18.93% in one year.
Market Cap
84.14M
Enterprise Value
2.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
351.80
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 84.14M, a decrease of -77.14%. That is a compound annual growth rate of -21.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 73.61B |
Danel (Adir Yeoshua) | 2.35B |
Kamada | 1.39B |
Bait Bakfar | 1.15B |
Novolog (Pharm-Up 1966) | 774.95M |
SofWave Medical | 722.24M |
Ilex Medical | 680.80M |
BrainsWay | 586.43M |